FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel compounds of the formula (I) , racemic and diastereomeric mixtures and optical isomers of these compounds and their pharmaceutically acceptable salts and prodrugs where e = 0 or 1; n and w = 1; Y means oxygen atom; R1 means hydrogen atom, -(CH2)t-A1 where t = 0, 1 or 2; A1 means phenyl or totally unsaturated 4-8-membered ring having optionally 1-2 hetero- -atoms taken independently among the group including sulfur and nitrogen atom, bicyclic system consisting of totally unsaturated 5- or 6-membered ring having optionally 1- 2 hetero- -atoms as nitrogen atom; in each case A1 is substituted optionally and independently at one or optionally at both rings if A1 means bicyclic ring system and has up to two substituents and each substituent is taken among the group including the following groups: F, Cl, Br, OCF3, (C1-C6)-alkyl, phenyl; R2 means hydrogen atom, (C1-C8)-alkyl where alkyl group is substituted optionally with CF3; R3 means (C1-C5)-alkyl-X1-(C0-C5)- -alkyl-A1 where X1 means -O-; values for A1 are given above; R4 means hydrogen atom; X4 means hydrogen atom; R6 means a residue of the formula (II) X5 where a and b = 0; X5a and (C1-C6) each means independently unsubstituted Z1-alkyl; R7 means a bond; R8 and each means hydrogen atom. Compounds of the formula (I) are stimulators of growth hormone and can be used for treatment and prophylaxis of patients with osteoporosis. EFFECT: new compounds indicated above, valuable medicinal properties. 94 cl, 183 ex
Title |
Year |
Author |
Number |
PHARMACEUTICAL COMPOSITION AND SET FOR TREATMENT OF REDUCED OSSEOUS MASS (VERSIONS) |
1996 |
- Ke Khua Zu
- Tompson Dehvid D.
|
RU2190395C2 |
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING |
1996 |
- Allen Jakob Daplehntir
- Kelvin Kuper
|
RU2161158C2 |
BENZOPYRANE AND BENZOCONDENSED COMPOUNDS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND A METHOD OF INHIBITION |
1995 |
- Mark A.Dombroski
- Kevin Kokh
- Ehntoni Daniehl' Piskop'O
|
RU2128655C1 |
BENZOFUSED COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF THEIR SYNTHESIS AND A METHOD OF SYNTHESIS OF AN INTERMEDIATE COMPOUND |
1992 |
|
RU2114110C1 |
COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND PROPHYLAXIS OF ENDOMETRITIS, INTERMEDIATE COMPOUND |
1996 |
- Kimberli O.Kameron
- Pol' A.Dasilva Zhardine
- Robert L.Rozati
|
RU2130454C1 |
INTERMEDIATES AND METHOD OF PREPARING NAPHTHIRIDONE CARBOXYLIC ACID SALTS |
1994 |
- Tamim F.Brejsh
- Darrell E.Foks
- Timoti Norris
- Piter R.Rouz
|
RU2147303C1 |
POLYMORPHIC FORMS |
2014 |
- Sudo Masaki
- Simada Kaoru
- Vakabayasi Khiroaki
- Numata Tojokharu
|
RU2670978C9 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND |
1993 |
- Dzhen M.Brajt
- Uillard M.Uehlch
|
RU2130453C1 |
HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS |
2020 |
- Van, Chzhunkhoj
- Li, Lin
- U, Frank
|
RU2793850C2 |
SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINEAMIDES AND THEIR DERIVATIVES, METHODS OF TREATMENT OF PATIENTS AND PHARMACEUTICAL COMPOSITION |
1996 |
- Bernard Khalin
- Dzhudit Li Tridvej
- Vill'Jam Kholt Martin
- Dennis Dzhej Khuver
- Duglas Fillips
|
RU2143424C1 |